(Reuters) - More than 100 vaccines are being developed and tested around the world to stop the COVID-19 pandemic, which has killed hundreds of thousands and ravaged the global economy.
The following is a list of major drugmakers and research institutes that have started or are planning to start human trials for their vaccine candidates.
For a separate FACTBOX on treatments under development, click here:
Date of Company Progress Development Story link
July 16 Johnson & In talks with Japan, Bill and Early stage
Johnson Melinda Gates Foundation, and the trials to start
European Union for vaccine as soon as July
allocations, Reuters reported. 22, late-stage
June 14 AstraZeneca Has signed deals to expand future Mid-stage
Plc supply of the vaccine it licensed studies.
from University of Oxford.
July 7 Novavax Inc The U.S. government has awarded Early-stage
$1.6 billion to test and testing.
manufacture its experimental
June 18 Sinopharm The Chinese state-owned company is Early-to-mid
developing two vaccines, one of stage trials.
which has shown promise in humans.
July 13 BioNTech SE The German drugmaker is working Being tested in
with Pfizer Inc to make 100 million early- to
doses of an experimental vaccine by mid-stage
the end of the year. trials
July 14 Moderna Inc Lonza aims to speed completion of Plans to start
two commercial production lines for late-stage
Moderna’s trial COVID-19 vaccine. trial on July
June 29 CanSino Early results showed the Being tested in
Biologics China-based company’s vaccine is a mid-stage
safe. China’s military has received trial.
the greenlight to use the vaccine.
May 14 GlaxoSmithKl Partnered with Sanofi SA to develop Early stage
ine Plc a vaccine. trials to begin
in second half
June 17 CureVac The unlisted German biotech expects Launched
data in September or October. early-stage
June 30 Inovio Vaccine candidate, found to be Mid-stage
Pharma safe, induced immune responses in testing.
healthy volunteers in an early
July 6 Sinovac The China-based vaccine maker has Has begun
Biotech Ltd released positive preliminary late-stage
results from early-stage trials of trials.
July 8 Clover The Chinese developer received $66 Launched human
Biopharmaceu million in investment from an trials.
ticals epidemic response group.
June 15 Not Scientists at Imperial College Early-stage
applicable London are running trials of a trials.
potential coronavirus vaccine.
June 21 Not Researchers at Institute of Medical Mid-stage
applicable Biology at Chinese Academy of trials.
Medical Sciences are testing a
June 19 Genexine Inc South Korea’s Genexine has begun Early-stage
human trials of its vaccine. trials.
July 10 Chongqing The Chinese company’s unit Anhui Mid-stage
Zhifei Zhifei Longcom Biopharmaceutical trial.
Biological has begun human trials.
July 13 Not The Gamaleya Research Institute in Early-stage
applicable Russia has begun human trials of an trials.
experimental vaccine, with results
expected in August.
June 29 Bharat Vaccine approved for human trials Early- to
Biotech in India. mid-stage
trials to start
June 24 Walvax Trials sponsored by the China-based Early-stage
Biotechnolog company, along with a Chinese studies.
y Co military research institute, have
July 14 Medicago The Canadian company is studying a Early-stage
plant-based vaccine. trials.
July 17 Cadila Plans to finish late-stage trials Early-stage
Healthcare by early 2021. trials.
July 14 Not University of Queensland began Early-stage (bit.ly/2OBrGLu)
applicable human trials in collaboration with testing.
Australian biotech company CSL,
according to a list compiled by the
World Health Organization.
Reporting by Vishwadha Chander and Manas Mishra in Bengaluru; Editing by Maju Samuel and Sriraj Kalluvila